Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy
| Autor: | Schwartzberg, L. *, Roeland, E., Andric, Z., Kowalski, D., Radic, J., Voisin, D., Rizzi, G., Navari, R., Gralla, R.J., Karthaus, M. |
|---|---|
| Zdroj: | In Annals of Oncology July 2018 29(7):1535-1540 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|